A Systematic Review of the Cost-Effectiveness of Biologics for the Treatment of Inflammatory Bowel Diseases

BACKGROUND: Biologics are used for the treatment of inflammatory bowel diseases, Crohn´s disease and ulcerative colitis refractory to conventional treatment. In order to allocate healthcare spending efficiently, costly biologics for inflammatory bowel diseases are an important target for cost-effect...

Descripción completa

Detalles Bibliográficos
Autores principales: Huoponen, Saara, Blom, Marja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682717/
https://www.ncbi.nlm.nih.gov/pubmed/26675292
http://dx.doi.org/10.1371/journal.pone.0145087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682717/
https://www.ncbi.nlm.nih.gov/pubmed/26675292
http://dx.doi.org/10.1371/journal.pone.0145087

Ejemplares similares